Quantum BioPharma Overview
- Year Founded
-
1994
- Status
-
Public
- Employees
-
8
- Stock Symbol
-
QNTM
- Investments
-
7
- Share Price
-
$3.40
- (As of Friday Closing)
Quantum BioPharma General Information
Description
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
Contact Information
Website
www.quantumbiopharma.comCorporate Office
- 55 University Avenue
- Suite 1003
- Toronto, Ontario M5J 2H7
- Canada
Corporate Office
- 55 University Avenue
- Suite 1003
- Toronto, Ontario M5J 2H7
- Canada
Quantum BioPharma Stock Performance
As of 17-Jan-2025, Quantum BioPharma’s stock price is $3.40. Its current market cap is $6.53M with 1.92M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.40 | $3.32 | $2.71 - $71.14 | $6.53M | 1.92M | 4.01K | -$12.68 |
Quantum BioPharma Financials Summary
As of 30-Sep-2024, Quantum BioPharma has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 3,742 | 31,604 | 6,014 | 2,933 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (11,174) | (16,510) | (22,488) | (29,824) |
| Net Income | (10,237) | (17,902) | (23,607) | (35,285) |
| Total Assets | 19,027 | 17,475 | 38,411 | 62,963 |
| Total Debt | 373 | 339 | 516 | 556 |
Quantum BioPharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Quantum BioPharma Comparisons
Industry
Financing
Details
Quantum BioPharma Competitors (3)
One of Quantum BioPharma’s 3 competitors is Oxford Cannabinoid Technologies, a Formerly VC-backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oxford Cannabinoid Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
| Revive Therapeutics | Corporation | Toronto, Canada | ||||
| Tetra Bio-Pharma | Corporation | Orleans, Canada |
Quantum BioPharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Quantum BioPharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Quantum BioPharma Investments & Acquisitions (7)
Quantum BioPharma’s most recent deal was a Corporate with Celly Nutrition for . The deal was made on 09-Aug-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Celly Nutrition | 09-Aug-2024 | Corporate | Pharmaceuticals | ||
| Lucid Psycheceuticals | 21-Sep-2021 | Merger/Acquisition | Drug Discovery | ||
| Prismic Pharmaceuticals | 28-Jun-2019 | Merger/Acquisition | Biotechnology | ||
| FSD Jamaica | 13-Sep-2018 | Joint Venture | Pharmaceuticals | ||
| Cannara Biotech | 19-Jul-2018 | Corporate | Cultivation |
Quantum BioPharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Quantum BioPharma Exits (1)
Quantum BioPharma’s most recent exit was on 19-Jul-2018 from Cannara Biotech. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Cannara Biotech | 19-Jul-2018 | Completed |
|
Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Lucid Psycheceuticals | Toronto, Canada | 2020 | |
| FSD Atlantic Pharma | St. John's, Canada | 2018 | |
| FV Pharma | Cobourg, Canada | 1994 |
Quantum BioPharma FAQs
-
When was Quantum BioPharma founded?
Quantum BioPharma was founded in 1994.
-
Where is Quantum BioPharma headquartered?
Quantum BioPharma is headquartered in Toronto, Canada.
-
What is the size of Quantum BioPharma?
Quantum BioPharma has 8 total employees.
-
What industry is Quantum BioPharma in?
Quantum BioPharma’s primary industry is Biotechnology.
-
Is Quantum BioPharma a private or public company?
Quantum BioPharma is a Public company.
-
What is Quantum BioPharma’s stock symbol?
The ticker symbol for Quantum BioPharma is QNTM.
-
What is the current stock price of Quantum BioPharma?
As of 17-Jan-2025 the stock price of Quantum BioPharma is $3.40.
-
What is the current market cap of Quantum BioPharma?
The current market capitalization of Quantum BioPharma is $6.53M.
-
Who are Quantum BioPharma’s competitors?
Oxford Cannabinoid Technologies, Revive Therapeutics, and Tetra Bio-Pharma are competitors of Quantum BioPharma.
-
What is Quantum BioPharma’s annual earnings per share (EPS)?
Quantum BioPharma’s EPS for 12 months was -$12.68.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
